Literature DB >> 27156766

Diabetes insipidus during pregnancy.

Sonia Ananthakrishnan1.   

Abstract

Diabetes insipidus (DI) in pregnancy is a heterogeneous syndrome, most classically presenting with polyuria and polydipsia that can complicate approximately 1 in 30,000 pregnancies. The presentation can involve exacerbation of central or nephrogenic DI during pregnancy, which may have been either overt or subclinical prior to pregnancy. Women without preexisting DI can also be affected by the actions of placental vasopressinase which increases in activity between the 4th and 38th weeks of gestation, leading to accelerated metabolism of AVP and causing a transient form of DI of pregnancy. This type of DI may be associated with certain complications during pregnancy and delivery, such as preeclampsia. Management of DI of pregnancy depends on the pathophysiology of the disease; forms of DI that lack AVP can be treated with desmopressin (DDAVP), while forms of DI that involve resistance to AVP require evaluation of the underlying causes.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  desmopressin; diabetes insipidus; pituitary; polydipsia; polyuria; pregnancy; vasopressin (AVP)

Mesh:

Substances:

Year:  2016        PMID: 27156766     DOI: 10.1016/j.beem.2016.02.005

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  7 in total

Review 1.  Desmopressin therapy in children and adults: pharmacological considerations and clinical implications.

Authors:  Xinyi Chin; Shao Wei Teo; Soo Ting Lim; Yong Hong Ng; How Chuan Han; Fabian Yap
Journal:  Eur J Clin Pharmacol       Date:  2022-02-23       Impact factor: 2.953

Review 2.  Diagnosis and Management of Central Diabetes Insipidus in Adults.

Authors:  Maria Tomkins; Sarah Lawless; Julie Martin-Grace; Mark Sherlock; Chris J Thompson
Journal:  J Clin Endocrinol Metab       Date:  2022-09-28       Impact factor: 6.134

Review 3.  Diabetes Insipidus: Pathogenesis, Diagnosis, and Clinical Management.

Authors:  Cody M Mutter; Trevor Smith; Olivia Menze; Mariah Zakharia; Hoang Nguyen
Journal:  Cureus       Date:  2021-02-23

Review 4.  Challenges and improvement needs in the care of patients with central diabetes insipidus.

Authors:  H Teare; J Argente; M Dattani; J Leger; M Maghnie; M Sherlock; G-C Ali; J Francombe; S Marjanovic
Journal:  Orphanet J Rare Dis       Date:  2022-02-16       Impact factor: 4.123

5.  Hypopituitarism and pregnancy: clinical characteristics, management and pregnancy outcome.

Authors:  Anna Aulinas; Nicole Stantonyonge; Apolonia García-Patterson; Juan M Adelantado; Carmen Medina; Juan José Espinós; Esther López; Susan M Webb; Rosa Corcoy
Journal:  Pituitary       Date:  2021-11-30       Impact factor: 4.107

6.  The clinical course and pathophysiological investigation of adolescent gestational diabetes insipidus: a case report.

Authors:  Tatsuya Kondo; Miwa Nakamura; Sayaka Kitano; Junji Kawashima; Takeshi Matsumura; Takashi Ohba; Munekage Yamaguchi; Hidetaka Katabuchi; Eiichi Araki
Journal:  BMC Endocr Disord       Date:  2018-01-30       Impact factor: 2.763

7.  Novel AVPR2 variant in a male infant with nephrogenic diabetes insipidus who showed delayed head control.

Authors:  Kosei Hasegawa; Hiromi Ihoriya; Natsuko Futagawa; Yousuke Higuchi; Hiroki Tsuchiya; Takashi Shibata; Yumiko Hayashi; Katsuhiro Kobayashi; Hirokazu Tsukahara
Journal:  Clin Pediatr Endocrinol       Date:  2019-10-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.